Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 28
Filtrar
Más filtros

Medicinas Complementárias
Tipo del documento
Intervalo de año de publicación
1.
Infect Dis Poverty ; 12(1): 44, 2023 Apr 25.
Artículo en Inglés | MEDLINE | ID: mdl-37098581

RESUMEN

BACKGROUND: The goal to eliminate the parasitic disease of poverty schistosomiasis as a public health problem is aligned with the 2030 United Nations agenda for sustainable development goals, including universal health coverage (UHC). Current control strategies focus on school-aged children, systematically neglecting adults. We aimed at providing evidence for the need of shifting the paradigm of schistosomiasis control programs from targeted to generalized approaches as key element for both the elimination of schistosomiasis as a public health problem and the promotion of UHC. METHODS: In a cross-sectional study performed between March 2020 and January 2021 at three primary health care centers in Andina, Tsiroanomandidy and Ankazomborona in Madagascar, we determined prevalence and risk factors for schistosomiasis by a semi-quantitative PCR assay from specimens collected from 1482 adult participants. Univariable and multivariable logistic regression were performed to evaluate odd ratios. RESULTS: The highest prevalence of S. mansoni, S. haematobium and co-infection of both species was 59.5%, 61.3% and 3.3%, in Andina and Ankazomborona respectively. Higher prevalence was observed among males (52.4%) and main contributors to the family income (68.1%). Not working as a farmer and higher age were found to be protective factors for infection. CONCLUSIONS: Our findings provide evidence that adults are a high-risk group for schistosomiasis. Our data suggests that, for ensuring basic health as a human right, current public health strategies for schistosomiasis prevention and control need to be re-addressed towards more context specific, holistic and integrated approaches.


Asunto(s)
Esquistosomiasis Urinaria , Esquistosomiasis mansoni , Adulto , Animales , Humanos , Masculino , Estudios Transversales , Madagascar/epidemiología , Prevalencia , Schistosoma haematobium , Schistosoma mansoni , Esquistosomiasis Urinaria/complicaciones , Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis Urinaria/prevención & control , Esquistosomiasis mansoni/complicaciones , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/prevención & control , Factores de Riesgo , Adulto Joven , Persona de Mediana Edad , Factores Sexuales , Agricultura/estadística & datos numéricos , Coinfección/epidemiología , Coinfección/parasitología
2.
BMC Public Health ; 20(1): 769, 2020 May 24.
Artículo en Inglés | MEDLINE | ID: mdl-32448159

RESUMEN

BACKGROUND: Schistosoma mansoni (S. mansoni) infection is a significant public health problem in Ethiopia, and has wide distribution in the country. The impact of the disease is particularly high on school-age children. Nationwide 385 endemic districts were identified, whereby control and elimination interventions are underway using school-based annual mass drug administration (MDA) with praziquantel. The national elimination program targets endemic districts as a whole. The aim of this study was to identify the transmission foci of Schistosoma mansoni and determine prevalence of soil-transmitted helminths (STHs) in Abeshge district. METHODS: The study was conducted from April to May, 2019 among school-age children randomly selected from public elementary schools in Abeshge district, South-central Ethiopia. Demographic information and data on risk factors of S. mansoni infection were gathered using pre-tested questionnaire. Moreover, a stool sample was collected from each child and examined using Kato-Katz thick smear technique. The data were analyzed using STATA_MP version 12. RESULTS: A total of 389 school-age children from five public elementary schools were included in the study. The overall prevalence of S. mansoni and STHs was 19.3% (75/389) and 35% (136/389), respectively. The prevalence of S. mansoni was 60.6% in Kulit Elementary school, while it was zero in Geraba. The prevalence of S. mansoni was significantly higher among males (AOR = 2.6, 95% CI 1.3-5.1), those with habit of swimming and/or bathing in rivers (AOR = 2.9, 95%CI 1.3-5.1) and involved in irrigation activities (AOR = 2.9, 95% CI 1.0-8.3). Overall, the prevalence of S. mansoni was significantly higher among school children attending Kulit Elementary School compared to those attending the remaining schools (AOR = 12.5, 95%CI 6.2-25.1). CONCLUSION: A wide variation of S. mansoni prevalence was observed among the school children in the different schools. Control interventions better identify and target foci of S. mansoni transmission, instead of targeting the district homogenously.


Asunto(s)
Antihelmínticos/uso terapéutico , Transmisión de Enfermedad Infecciosa/prevención & control , Praziquantel/uso terapéutico , Schistosoma mansoni , Esquistosomiasis mansoni/transmisión , Adolescente , Animales , Niño , Preescolar , Estudios Transversales , Etiopía/epidemiología , Heces/parasitología , Femenino , Humanos , Masculino , Administración Masiva de Medicamentos/estadística & datos numéricos , Prevalencia , Salud Pública , Factores de Riesgo , Ríos/parasitología , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/prevención & control , Servicios de Salud Escolar/estadística & datos numéricos , Instituciones Académicas , Suelo/parasitología , Encuestas y Cuestionarios
3.
Pathog Glob Health ; 113(3): 101-108, 2019 05.
Artículo en Inglés | MEDLINE | ID: mdl-30983544

RESUMEN

Schistosomiasis is a parasitic disease caused by helminths of the genus Schistosoma with two presentations; one intestinal and another urinary; which depend on the specie of Schistosoma. One of the species that can produce intestinal schistosomiasis is Schistosoma mansoni, and the specie that produces urinary schistosomiasis is Schistosoma haematobium. Infection can be aggravated by a deficient nutritional status, which negatively impacts the immune system and increases susceptibility to infection. The main objective of this meta-analysis is to determine if a relationship exists between multimicronutrient supplementation and the reduction of infestation with Schistosoma mansoni and Schistosoma haematobium in children and adolescents. A search was conducted through a scientific literature database, and articles that complied with the pre-established requirements were retrieved. The Review Manager (Rev Man) 5.3 computer program was used for data processing and analysis was carried out with the objective of testing whether the addition of micronutrient supplementation to treatment with broad-spectrum antiparasitic anthelmintic medication has an impact on schistosomiasis infection. Of the 257 initial articles retrieved, eight were included both quantitatively and qualitatively in the meta-analysis. Supplementation reduces infestation with Schistosoma spp 1.33 times more than placebo. In individuals infested with Schistosoma, mansoni supplementation is 1.30 times more effective than placebo and for individuals infested with Schistosoma haematobium, supplementation is 1.62 times more effective than the placebo. The results show a clear relationship between supplementation and reduction of infestation. The supplementation with micronutrients decreases the presence of Schistosoma spp in children and adolescents.


Asunto(s)
Micronutrientes/administración & dosificación , Estado Nutricional , Schistosoma haematobium/aislamiento & purificación , Schistosoma mansoni/aislamiento & purificación , Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis mansoni/epidemiología , Adolescente , Animales , Niño , Preescolar , Femenino , Humanos , Masculino , Placebos/administración & dosificación
4.
Parasit Vectors ; 10(1): 593, 2017 Dec 02.
Artículo en Inglés | MEDLINE | ID: mdl-29197426

RESUMEN

BACKGROUND: Schistosoma mansoni is a parasite of profound medical importance. Current control focusses on mass praziquantel (PZQ) treatment of populations in endemic areas, termed Preventative Chemotherapy (PC). Large-scale PC programmes exert prolonged selection pressures on parasites with the potential for, direct and/or indirect, emergence of drug resistance. Molecular methods can help monitor genetic changes of schistosome populations over time and in response to drug treatment, as well as estimate adult worm burdens through parentage analysis. Furthermore, methods such as in vitro drug sensitivity assays help phenotype in vivo parasite genotypic drug efficacy. METHODS: We conducted combined in vitro PZQ efficacy testing with population genetic analyses of S. mansoni collected from children from two schools in 2010, five years after the introduction of a National Control Programme. Children at one school had received four annual PZQ treatments and the other school had received two mass treatments in total. We compared genetic differentiation, indices of genetic diversity, and estimated adult worm burden from parasites collected in 2010 with samples collected in 2005 (before the control programme began) and in 2006 (six months after the first PZQ treatment). Using 2010 larval samples, we also compared the genetic similarity of those with high and low in vitro sensitivity to PZQ. RESULTS: We demonstrated that there were individual parasites with reduced PZQ susceptibility in the 2010 collections, as evidenced by our in vitro larval behavioural phenotypic assay. There was no evidence, however, that miracidia showing phenotypically reduced susceptibility clustered together genetically. Molecular analysis also demonstrated a significant reduction of adult worm load over time, despite little evidence of reduction in parasite infection intensity, as measured by egg output. Genetic diversity of infections did not reduce over time, despite changes in the genetic composition of the parasite populations. CONCLUSIONS: Genotypic and phenotypic monitoring did not indicate a selective sweep, as may be expected if PZQ treatment was selecting a small number of related "resistant" parasites, but there was evidence of genetic changes at the population level over time. Genetic data were used to estimate adult worm burdens, which unlike parasite infection intensity, showed reductions over time, suggesting the relaxation of negative density-dependent constraints on parasite fecundity with PZQ treatment. We thereby demonstrated that density-dependence in schistosome populations may complicate evaluation and monitoring of control programmes.


Asunto(s)
Resistencia a Medicamentos , Variación Genética , Praziquantel/uso terapéutico , Esquistosomiasis mansoni/prevención & control , Esquistosomiasis mansoni/parasitología , Animales , Antihelmínticos/administración & dosificación , Antihelmínticos/uso terapéutico , Niño , Genotipo , Humanos , Programas Nacionales de Salud , Praziquantel/administración & dosificación , Schistosoma mansoni/efectos de los fármacos , Esquistosomiasis mansoni/epidemiología , Tanzanía/epidemiología
5.
Acta Trop ; 149: 155-62, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25940353

RESUMEN

This study evaluated a school-based and a community-based scheme for diagnosis, treatment and follow-up of schistosomiasis mansoni among school-aged children in views of resolution CD49.R19 of the Pan American Health Organization toward the elimination of schistosomiasis as a public health problem in the Americas and subsequent commitments endorsed by the Brazilian government. The school-aged population from a representative municipality of the endemic area of Northeastern Brazil was randomly allocated to either school-based or community-based scheme. The two schemes were compared with regard to coverage of diagnosis by the Kato-Katz method (KK) at baseline, treatment of the positives for Schistosoma mansoni with praziquantel, treatment of the positives for soil-transmitted helminthes (STH) with mebendazole, as well as follow-up of treatment efficacy and reinfection assessed respectively at four and 12 months after treatment. Nutritional status of the positives for S. mansoni was assessed at baseline and re-assessed at 12 months after treatment. Coverage of diagnosis and treatment was satisfactory (>75%) in both schemes. Diagnosis coverage at baseline and at 12 months was significantly higher in the community scheme, whereas treatment coverage did not differ significantly between the two schemes either at baseline or at 12 months. The number of children covered per day was significantly higher in the schools than in the community at baseline but not at follow-up, when daily coverage was higher in the community. With regard to S. mansoni, overall treatment efficacy rate at four months was 90.8%, and reinfection rate at 12 months was 21.6%. For STH, overall treatment efficacy was 45.4% and reinfection, 32.8%. The nutritional status of the positives for S. mansoni at baseline did not change significantly at 12 months post-treatment. Actions targeted at this particularly vulnerable high-risk group should combine school-based and community-based interventions as well as preventive measures to reduce transmission.


Asunto(s)
Antihelmínticos/uso terapéutico , Servicios de Salud Comunitaria/métodos , Enfermedades Endémicas , Mebendazol/uso terapéutico , Praziquantel/uso terapéutico , Esquistosomiasis mansoni/tratamiento farmacológico , Servicios de Salud Escolar , Adolescente , Animales , Brasil/epidemiología , Niño , Participación de la Comunidad , Heces , Femenino , Humanos , Masculino , Características de la Residencia , Schistosoma mansoni , Esquistosomiasis mansoni/diagnóstico , Esquistosomiasis mansoni/epidemiología , Instituciones Académicas , Enfermedades de la Piel , Suelo/parasitología , Factores de Tiempo , Resultado del Tratamiento
6.
Geospat Health ; 7(1): 1-13, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-23242675

RESUMEN

The establishment of a national control programme (NCP) in Uganda has led to routine treatment of intestinal schistosomiasis with praziquantel in the communities along Lake Albert. However, because regular water contact remains a way of life for these populations, re-infection continues to mitigate the sustainability of the chemotherapy-based programme. A six-month longitudinal study was conducted in one Lake Albert community with the aim of characterizing water contact exposure and infection among mothers and their young preschool-aged children as the latter are not yet formally included within the NCP. At baseline the cohort of 37 mothers, 36 preschool-aged children had infection prevalences of 62% and 67%, respectively, which diminished to 20% and 29%, respectively, at the 6-month post-treatment follow-up. The subjects wore global positioning system (GPS) datalogging devices over a 3-day period shortly after baseline, allowing for the estimation of time spent at the lakeshore as an exposure metric, which was found to be associated with prevalence at follow-up (OR = 2.1, P = 0.01 for both mothers and young children and odds ratio (OR) = 4.4, P = 0.01 for young children alone). A social network of interpersonal interactions was also derived from the GPS data, and the exposures were positively associated both with the number and duration of peer interaction, suggesting the importance of socio-cultural factors associated with water contact behaviour. The findings illustrate reduction in both prevalence and intensity of infection in this community after treatment as well as remarkably high rates of water contact exposure and re-infection, particularly among younger children. We believe that this should now be formally considered within NCP, which may benefit from more in-depth ethnographic exploration of factors related to water contact as this should provide new opportunities for sustaining control.


Asunto(s)
Exposición a Riesgos Ambientales/estadística & datos numéricos , Praziquantel/uso terapéutico , Esquistosomiasis mansoni/epidemiología , Microbiología del Agua , Albendazol/uso terapéutico , Animales , Antihelmínticos/uso terapéutico , Cercarias/parasitología , Niño , Preescolar , Exposición a Riesgos Ambientales/efectos adversos , Femenino , Sistemas de Información Geográfica , Humanos , Estudios Longitudinales , Masculino , Madres/estadística & datos numéricos , Proyectos Piloto , Prevalencia , Schistosoma mansoni/aislamiento & purificación , Schistosoma mansoni/patogenicidad , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/prevención & control , Prevención Secundaria , Conducta Social , Uganda/epidemiología
7.
Parasitology ; 138(12): 1586-92, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21349218

RESUMEN

OBJECTIVE: There is limited information on the acceptability and safety of praziquantel for treatment of schistosomiasis in children below the age of four years. In addition, although mebendazole has been extensively used together with praziquantel against infections with schistosomiasis and soil-transmitted helminthiasis (STH) in school-aged children, no specific acceptability or safety studies have been published on this drug combination in younger children. METHODS: A randomized clinical trial was conducted to determine the safety of praziquantel alone and in combination with mebendazole in the treatment of Schistosoma mansoni and STH in children aged 1 to 4 years. RESULTS: A total of 596 children from Bwondha fishing community in Mayuge district and Wang-Kado fishing community in Nebbi district were investigated using duplicate Kato-Katz thick smears of two stool samples and 130 (21·8%) were found infected with S. mansoni. Of these, 19·2% (25) had heavy intensity of infections. Of the infected children, 82 were included and randomised into praziquantel (40 mg/kg) + mebendazole (500 mg) or praziquantel (40 mg/kg) alone. CONCLUSION: Many symptoms were reported before treatment while very few were reported after treatment and all on treatment day. No serious adverse events were reported or observed after treatment. Praziquantel with or without mebendazole was well tolerated in small children in the study area.


Asunto(s)
Antihelmínticos/administración & dosificación , Helmintiasis/tratamiento farmacológico , Mebendazol/administración & dosificación , Praziquantel/administración & dosificación , Esquistosomiasis mansoni/tratamiento farmacológico , Animales , Antihelmínticos/efectos adversos , Ascariasis/tratamiento farmacológico , Ascariasis/parasitología , Ascaris lumbricoides/aislamiento & purificación , Preescolar , Quimioterapia Combinada , Heces/parasitología , Femenino , Helmintiasis/complicaciones , Helmintiasis/epidemiología , Infecciones por Uncinaria/tratamiento farmacológico , Infecciones por Uncinaria/epidemiología , Humanos , Lactante , Masculino , Mebendazol/efectos adversos , Recuento de Huevos de Parásitos , Praziquantel/efectos adversos , Prevalencia , Schistosoma mansoni/aislamiento & purificación , Esquistosomiasis mansoni/complicaciones , Esquistosomiasis mansoni/epidemiología , Método Simple Ciego , Suelo/parasitología , Encuestas y Cuestionarios , Resultado del Tratamiento , Tricuriasis/tratamiento farmacológico , Tricuriasis/epidemiología , Uganda/epidemiología
8.
Mem Inst Oswaldo Cruz ; 105(4): 519-23, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20721502

RESUMEN

The Schistosomiasis Control Program (PCE) was implemented in Minas Gerais (MG) in 1984. In 1999, the state started the investigation and control of schistosomiasis in 470 municipalities. The aim of the present paper is to report the evolution of this Program from 1984-2007. The program included a coproscopic survey carried out in the municipalities of known endemic areas using a quantitative method. Positives were treated with praziquantel and given a program of health education. The information for this study was obtained from data collected and stored by the Health State Department. From 2003-2007, 2,643,564 stool examinations resulted in 141,284 positive tests for Schistosoma mansoni (5.3%). In the first evaluation after treatment, a decrease in the number of municipalities with prevalence over 10% was documented. In one village, selected for a more detailed evaluation, the percentage of positive tests decreased from 14.9% in the baseline survey to 5.3% after treatment. A reference centre for patients with severe schistosomiasis was created in Belo Horizonte, MG. Based on our findings, we believe that the implementation of PCE in MG is on the right path and in due time these new initiatives will provide desirable results.


Asunto(s)
Antihelmínticos/uso terapéutico , Heces/parasitología , Praziquantel/uso terapéutico , Schistosoma mansoni/aislamiento & purificación , Esquistosomiasis mansoni/prevención & control , Animales , Brasil/epidemiología , Educación en Salud , Humanos , Programas Nacionales de Salud , Prevalencia , Evaluación de Programas y Proyectos de Salud , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/epidemiología
9.
Mem Inst Oswaldo Cruz ; 105(4): 563-9, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20721509

RESUMEN

School-aged children (6-15 years) from the endemic area of Pernambuco were evaluated both as a target group for and an indicator of schistosomiasis control in the community. Parasitological data were drawn from baseline stool surveys of whole populations that were obtained to diagnose Schistosoma mansoni infection. Nineteen representative localities were selected for assessing the prevalence of schistosomiasis among individuals in the following age groups: 0-5, 6-15, 16-25, 26-40 and 41-80 years. For each locality, the prevalence in each age group was compared to that of the overall population using contingency table analysis. To select a reference group, the operational difficulties of conducting residential surveys were considered. School-aged children may be considered to be the group of choice as the reference group for the overall population for the following reasons: (i) the prevalence of schistosomiasis in this age group had the highest correlation with the prevalence in the overall population (r = 0.967), (ii) this age group is particularly vulnerable to infection and plays an important role in parasite transmission and (iii) school-aged children are the main target of the World Health Organization in terms of helminth control. The Schistosomiasis Control Program should consider school-aged children both as a reference group for assessing the need for intervention at the community level and as a target group for integrated health care actions of the Unified Health System that are focused on high-risk groups.


Asunto(s)
Enfermedades Endémicas , Esquistosomiasis mansoni/epidemiología , Adolescente , Adulto , Distribución por Edad , Anciano , Anciano de 80 o más Años , Brasil/epidemiología , Niño , Preescolar , Heces/parasitología , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Prevalencia , Esquistosomiasis mansoni/diagnóstico , Esquistosomiasis mansoni/prevención & control , Adulto Joven
10.
Trop Med Int Health ; 15(2): 198-207, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-20409287

RESUMEN

OBJECTIVE: To determine spatial patterns of co-endemicity of schistosomiasis mansoni and the soil-transmitted helminths (STHs) Ascaris lumbricoides, Trichuris trichiura and hookworm in the Great Lakes region of East Africa, to help plan integrated neglected tropical disease programmes in this region. METHOD: Parasitological surveys were conducted in Uganda, Tanzania, Kenya and Burundi in 28 213 children in 404 schools. Bayesian geostatistical models were used to interpolate prevalence of these infections across the study area. Interpolated prevalence maps were overlaid to determine areas of co-endemicity. RESULTS: In the Great Lakes region, prevalence was 18.1% for Schistosoma mansoni, 50.0% for hookworm, 6.8% for A. lumbricoides and 6.8% for T. trichiura. Hookworm infection was ubiquitous, whereas S. mansoni, A. lumbricoides and T. trichiura were highly focal. Most areas were endemic (prevalence >or=10%) or hyperendemic (prevalence >or=50%) for one or more STHs, whereas endemic areas for schistosomiasis mansoni were restricted to foci adjacent large perennial water bodies. CONCLUSION: Because of the ubiquity of hookworm, treatment programmes are required for STH throughout the region but efficient schistosomiasis control should only be targeted at limited high-risk areas. Therefore, integration of schistosomiasis with STH control is only indicated in limited foci in East Africa.


Asunto(s)
Helmintiasis/epidemiología , África Oriental/epidemiología , Animales , Ascariasis/epidemiología , Ascariasis/prevención & control , Ascaris lumbricoides , Prestación Integrada de Atención de Salud/métodos , Enfermedades Endémicas , Métodos Epidemiológicos , Femenino , Sistemas de Información Geográfica , Helmintiasis/prevención & control , Infecciones por Uncinaria/epidemiología , Infecciones por Uncinaria/prevención & control , Humanos , Masculino , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/prevención & control , Tricuriasis/epidemiología , Tricuriasis/prevención & control
11.
Bull World Health Organ ; 86(10): 780-7, A, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18949215

RESUMEN

OBJECTIVE: To evaluate the impact on schistosomiasis of biennial treatment with praziquantel (PZQ) among school-age children in Burkina Faso, the first country that achieved full national coverage with treatment of more than 90% of the school-age population. METHODS: A cohort of 1727 schoolchildren (6-14 years old) was monitored at yearly intervals through a longitudinal survey. Additional groups of schoolchildren were monitored in cross-sectional surveys. Parasitological examinations for Schistosoma haematobium and Schistosoma mansoni were performed, and prevalence and intensity of infection before and after treatment were analysed. FINDINGS: Data from the longitudinal cohort show that a single round of PZQ treatment significantly reduced prevalence of S. haematobium infection by 87% (from 59.6% to 7.7%) and intensity of infection by 92.8% (from 94.2 to 6.8 eggs/10 ml of urine) 2 years post-treatment. The impact on infection was also confirmed by a cross-sectional survey 2 years post-treatment. Importantly, the proportion of school-age children with heavy S. haematobium infection decreased from around 25% before treatment to around 2-3% 2 years post-treatment. Cross-sectional comparison of S. haematobium infection in 7-year-old children in their first year at school, who received treatment through community-based drug delivery, also showed significant reduction in both prevalence (65.9%) and intensity of S. haematobium infection (78.4%) 2 years after single treatment. A significant reduction in S. mansoni infection was also achieved. CONCLUSION: Significant and sustained reduction in S. haematobium infection was achieved by biennial treatment in school-age children in Burkina Faso. This may provide a cost-effective treatment strategy for similar national schistosomiasis control programmes in sub-Saharan Africa.


Asunto(s)
Antihelmínticos/uso terapéutico , Praziquantel/uso terapéutico , Prevención Primaria/métodos , Esquistosomiasis Urinaria/prevención & control , Esquistosomiasis mansoni/prevención & control , Adolescente , Burkina Faso/epidemiología , Niño , Estudios Transversales , Femenino , Humanos , Estudios Longitudinales , Masculino , Programas Nacionales de Salud , Esquistosomiasis Urinaria/tratamiento farmacológico , Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/epidemiología , Resultado del Tratamiento
12.
BMC Med ; 5: 27, 2007 Sep 03.
Artículo en Inglés | MEDLINE | ID: mdl-17767713

RESUMEN

BACKGROUND: Schistosomiasis and soil-transmitted helminthiasis (STH) are among the neglected tropical diseases in Africa. A national control program for these diseases was initiated in Uganda during March 2003. Annual treatment with praziquantel and albendazole was given to schoolchildren in endemic areas and to adults in selected communities where local prevalence of Schistosoma mansoni in schoolchildren was high. METHODS: The impact of the treatment program was monitored through cohorts of schoolchildren and adults. Their infection status with S. mansoni and STH was determined by parasitological examinations at baseline and at annual follow-ups. The prevalence and intensity of S. mansoni and STH before and after treatment were analyzed. RESULTS: Two rounds of treatment significantly reduced the prevalence of S. mansoni infection in schoolchildren across three regions in the country from 33.4-49.3% to 9.7-29.6%, and intensity of infection from 105.7-386.8 eggs per gram of faeces (epg) to 11.6-84.1 epg. The prevalence of hookworm infection was reduced from 41.2-57.9% to 5.5-16.1%, and intensity of infection from 186.9-416.8 epg to 3.7-36.9 epg. The proportion of children with heavy S. mansoni infection was significantly reduced from 15% (95% CI 13.4-16.8%) to 2.3% (95% CI 1.6-3.0%). In adults, significant reduction in the prevalence and intensity of S. mansoni and hookworm infections was also observed. More importantly, the prevalence and intensity of both S. mansoni and hookworm infections in the cohorts of newly-recruited 6-year-olds who had never previously received treatment decreased significantly over 2 years: 34.9% (95% CI 31.9-37.8%) to 22.6% (95% CI 19.9-25.2%) and 171.1 epg (95% CI 141.5-200.7) to 72.0 epg (95% CI 50.9-93.1) for S. mansoni; and 48.4% (95% CI 45.4-51.5) to 15.9% (95% CI 13.6-18.2) and 232.7 epg (95% CI 188.4-276.9) to 51.4 epg (95% CI 33.4-69.5) for hookworms, suggesting a general decline in environmental transmission levels. CONCLUSION: Annual anthelminthic treatment delivered to schoolchildren and to adults at high risk in Uganda can significantly reduce the prevalence and intensity of infection for schistosomiasis and STH, and potentially also significantly reduce levels of environmental transmission of infection.


Asunto(s)
Antineoplásicos/uso terapéutico , Esquistosomiasis mansoni/prevención & control , Suelo/parasitología , Adulto , Animales , Niño , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Helmintiasis/tratamiento farmacológico , Helmintiasis/epidemiología , Helmintiasis/prevención & control , Helmintiasis/transmisión , Humanos , Masculino , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/epidemiología , Uganda/epidemiología
13.
Trans R Soc Trop Med Hyg ; 99(10): 787-94, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16099007

RESUMEN

The endod (Phytolacca dodecandra)-based schistosomiasis mansoni control project was implemented in Ethiopia between 1994 and 1999. The aim was to develop an effective, cheap and sustainable method of controlling schistosomiasis. First, different formulations of the Ethiopian endod strain 44 (E-44) were compared for potency in the laboratory. Secondly, spray and drip-feeding methods were compared for simplicity and effectiveness in the field. Lastly, the efficacy of endod powder soap was compared with the endod spray method. In Bati stream, endod powder soap was distributed to the residents every weekend at laundry sites. In Worke stream, endod was sprayed along a 1-km stretch of the stream at 3-month intervals. No endod was applied in Harbu stream. The immediate and long-term effects of endod application on the snail population and schistosomal infection were determined. Using the spray method, 100% snail mortality could be obtained, and it was simpler and more effective than the drip-feeding method. Snail mortality ranged from 20 to 100% using endod soap. There was a progressive decline in the snail population and infection in Bati stream compared with Worke stream, mainly due to sustained use of endod soap. The advantages and disadvantages of the different endod delivery systems are discussed.


Asunto(s)
Vectores de Enfermedades , Moluscocidas/uso terapéutico , Control de Plagas/métodos , Phytolacca dodecandra , Esquistosomiasis mansoni/prevención & control , Jabones/uso terapéutico , Animales , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos/métodos , Etiopía/epidemiología , Moluscocidas/química , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/transmisión , Caracoles , Jabones/química
14.
Am J Trop Med Hyg ; 72(2): 119-23, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15741544

RESUMEN

This trial investigated the anti-schistosomal activity of mirazid in comparison with that of praziquantel in Schistosoma mansoni-infected Egyptian patients. The sample population was composed of 1,131 individuals (459 school children and 672 household members). Screening for S. mansoni was conducted using the standard Kato Katz technique. Four slides from a single stool sample were examined before treatment, and four slides per sample from stool samples obtained on three consecutive days were examined post-treatment. All positive eligible subjects were randomly assigned into two groups, the first received mirazid at a dose of 300 mg/day for three consecutive days, and the second received praziquantel at a single dose of 40 mg/kg. All treated subjects were examined 4-6 weeks post-treatment. Mirazid showed low cure rates of 9.1% and 8.9% in S. mansoni-infected school children and household members, respectively, compared with cure rates of 62.5% and 79.7%, respectively, in those treated with praziquantel. Therefore, we do not recommend mirazid as an agent to control schistosomiasis.


Asunto(s)
Fitoterapia , Praziquantel/uso terapéutico , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomicidas/uso terapéutico , Terpenos/uso terapéutico , Adolescente , Adulto , Anciano , Animales , Niño , Egipto/epidemiología , Composición Familiar , Heces/parasitología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Praziquantel/administración & dosificación , Schistosoma mansoni/aislamiento & purificación , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/etiología , Esquistosomiasis mansoni/prevención & control , Esquistosomicidas/administración & dosificación , Terpenos/administración & dosificación , Resultado del Tratamiento
15.
J Egypt Soc Parasitol ; 34(2): 423-46, 2004 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-15287168

RESUMEN

Schistosomiasis remains a public health problem in Egypt, despite the continuous control effort. Most of the anti-schistosomal drugs have deleterious side effects or low efficacy. This necessitates a search for new safe and effective drug. A field survey was done in Ezbet El-Bakly (Tamyia Center) El-Fayoum Governorate to determine the magnitude of schistosomiasis haematobium and mansoni and to evaluate the efficacy of Mirazid (the oleo-resin extract from Myrrh of Commiphora molmol tree, family: Burseraceae) in the treatment of both types of schistosomiasis. Among the 1019 individuals parasitologically examined, the prevalence of S. haematobium and S. mansoni were 4.2% and 2.4% respectively and the geometric mean egg count (GMEC) were 33.2 eggs/10 ml urine and 113.3 eggs/gram stools. Most of the patients with haematobiasis and mansoniasis were <15 years (56.4% & 53.8%), males (56.4% & 53.8%) & illiterates (46.2% & 46.2%). All cases were treated by Myrrh (Mirazid) as two capsules (600 mg) on an empty stomach an hour before breakfast for six consecutive days and were followed up clinically and parasitologically by urine analysis by the sedimentation and nucleopore techniques and by hatching test and by stool analysis by sedimentation and Kato-Katz techniques and by hatching test. The parasitological cure rate after three months was 97.4% and 96.2% for S. haematobium and S. mansoni cases with the marvelous clinical cure without any side-effects. Patients not completely responded to a single course of treatment showed marked reduction of egg intensity. It is concluded that Mirazid proved to be safe and very effective in treatment of S. haematobium and S. mansoni infections under field conditions.


Asunto(s)
Fitoterapia/métodos , Schistosoma haematobium , Schistosoma mansoni , Esquistosomiasis Urinaria/tratamiento farmacológico , Esquistosomiasis mansoni/tratamiento farmacológico , Terpenos/uso terapéutico , Adulto , Animales , Egipto/epidemiología , Femenino , Hematuria/parasitología , Humanos , Masculino , Persona de Mediana Edad , Extractos Vegetales/uso terapéutico , Tiras Reactivas , Población Rural , Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis Urinaria/parasitología , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/parasitología
16.
Eur J Clin Nutr ; 57(4): 573-9, 2003 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12700619

RESUMEN

OBJECTIVE: To assess the effects of multi-micronutrient supplementation and multi-helminth chemotherapy on haemoglobin concentration (Hb), using schools as a health delivery system. STUDY AREA AND POPULATION: Nine hundred seventy-seven children between 9 and 18 y of age from 19 primary schools in Bondo District, western Kenya, were included in the trial. The 746 (76.4%) children on whom baseline Hb was available were included in this study. DESIGN: The study was a randomized, placebo-controlled, double-blind, two-by-two factorial trial of the effects of multi-micronutrient supplementation and multi-helminth chemotherapy on Hb after 8 months. INTERVENTION: Single treatment of infected children with albendazole (600 mg) for geohelminths and praziquantel (40 mg/kg) for Schistosoma mansoni and daily supplementation with 13 micronutrients. RESULTS: : Multi-micronutrient supplementation (3.5 g/l, 95% CI 1.7, 5.3; P=0.0002) and anthelminthic treatment (2.0 g/l, 95% CI 0.2, 3.9; P=0.03) increased Hb independently (interaction, P=0.33). The effects were also independent of baseline Hb and general nutritional status. The treatment effect was due to reductions in S. mansoni and hookworm intensities of infection, in that Hb increased by 0.4 and 0.2 g/l, respectively, per 100 epg reductions in egg output. Interestingly, among S. mansoni-infected children, the effect of treatment seemed stronger in those with compared to those without co-existing malaria parasitaemia (interaction, P=0.09). CONCLUSION: Multi-micronutrient supplementation and multi-helminth chemotherapy increased Hb among school children, irrespective of initial Hb and nutritional status.


Asunto(s)
Antihelmínticos/administración & dosificación , Suplementos Dietéticos , Hemoglobinas/análisis , Micronutrientes/administración & dosificación , Adolescente , Albendazol/administración & dosificación , Anemia/tratamiento farmacológico , Anemia/etiología , Animales , Ascariasis/complicaciones , Ascariasis/tratamiento farmacológico , Ascariasis/epidemiología , Ascaris lumbricoides , Niño , Método Doble Ciego , Infecciones por Uncinaria/complicaciones , Infecciones por Uncinaria/tratamiento farmacológico , Infecciones por Uncinaria/epidemiología , Humanos , Kenia/epidemiología , Malaria/complicaciones , Malaria/tratamiento farmacológico , Malaria/epidemiología , Placebos , Praziquantel/administración & dosificación , Esquistosomiasis mansoni/complicaciones , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/epidemiología , Instituciones Académicas , Tricuriasis/complicaciones , Tricuriasis/tratamiento farmacológico , Tricuriasis/epidemiología
17.
East Afr Med J ; 79(4): 198-201, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-12625676

RESUMEN

OBJECTIVES: To record the effect of Endod soap and spraying of soaked Endod suspension on the prevalence of human schistosomiasis. DESIGN: A cross-sectional epidemiological study in which pre- and post-intervention parasitological results were compared. SETTING: Kemise, Bati and Harbu towns in northeastern Ethiopia. SUBJECTS: The study subjects included all members of the five per cent households systematically selected from the three towns. RESULTS: In Kemise town, where suspension of ground Endod was sprayed on the stream containing infected snails, the prevalence of the disease was reduced from 59% to 53% and the mean intensity of infection was reduced from 239 eggs per gram (EPG) of faeces to 99 EPG (p < 0.05). In Bati town where Endod soap approach was used, the respective reduction in the prevalence and intensity of infection was from 51% to 43% and from 195 EPG to 162 EPG (p < 0.05). There was also a significant reduction of the disease in the control town probably due to the effects of praziquantel treatment and other factors. CONCLUSION: The reduction achieved in the prevalence and intensity of schistosomiasis after an intervention period of four years was limited. This observation corroborates the fact that molluscicides must always be considered as supplementary to chemotherapy in the control of schistosomiasis. Although both approaches can be used, the spraying approach appears to be simpler and more feasible because two or three times yearly application of Endod suspension would suppress snail population and reduce transmission. Nevertheless, the choice as to what approach to use must be made on the basis of community preference, and for some soap-effect of Endod would be attractive


Asunto(s)
Vectores de Enfermedades , Agua Dulce/parasitología , Medicinas Tradicionales Africanas , Moluscocidas , Control de Plagas/métodos , Phytolacca dodecandra , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/prevención & control , Caracoles/parasitología , Adolescente , Adulto , Distribución por Edad , Animales , Niño , Estudios Transversales , Etiopía , Estudios de Factibilidad , Femenino , Humanos , Lavandería , Masculino , Control de Plagas/normas , Vigilancia de la Población , Prevalencia , Esquistosomiasis mansoni/parasitología , Esquistosomiasis mansoni/transmisión , Distribución por Sexo , Jabones , Suspensiones
18.
Saudi Med J ; 22(5): 428-32, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11376386

RESUMEN

OBJECTIVE: Prevalence, intensity and incidence of schistosomosis and soil-transmitted helminthosis among school children in an ignored area in Yemen were determined. The study aimed to investigate the impact of single doses of Praziquantel or Albenedazole or both, relating to sanitary, socioeconomic and behavioral practices on the prevalence and intensity of infections. METHODS: Out of a total number of 897 pupils, 453 were randomly selected from AlMahweet town and 444 from rural surrounding areas. Millipore filtration, modified Kato and precipitation techniques were applied for urine and stool analysis. RESULTS: Prevalence rates were 27% for schistosomosis, 61% for ascariosis, 21% for trichuriosis, 2% for fascilosis, 0.3% for entrobiosis, 0.7% for hook worm infection and 0.2% for strongloydiosis. Factors found confounding the relationship between schistosomosis and residence, under logistic regression analysis, were sex and frequency of water contact. Probability of infection by Bilharzia for boys who reside in rural AlMahweet and visit the water source is 0.52, compared to 0.30 for their mates who reside in AlMahweet town. Odds ratio estimates accounted for via residence was 2.5, via water contact 1.7 and via boys 3.2. With regards to other helminthic infections, availability of latrines remained the only significant factor under ANOVA. CONCLUSION: In conclusion, annual campaigns for treatment as a single control measure can reduce the infection rate of S. mansoni by 62.5%, T. trichura by 48% and A. lumbricoides by 24%. Whereas for S. hematobium the appropriate time interval for intervention should be shortened according to the findings of a properly designed intervention study before used as a single control measure. Since 77% of the children were infected by other helminthes, therefore mass treatment should be extended to cover all children. For those boys in rural AlMahweet who visited the water source during the week before the interview, mass treatment for schistosomosis is recommended since the prediction of infection rate reached 52%.


Asunto(s)
Albendazol/uso terapéutico , Antihelmínticos/uso terapéutico , Antiprotozoarios/uso terapéutico , Helmintiasis/tratamiento farmacológico , Helmintiasis/prevención & control , Praziquantel/uso terapéutico , Esquistosomiasis Urinaria/tratamiento farmacológico , Esquistosomiasis Urinaria/prevención & control , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/prevención & control , Suelo/parasitología , Agua/parasitología , Adolescente , Análisis de Varianza , Niño , Preescolar , Helmintiasis/epidemiología , Helmintiasis/transmisión , Humanos , Incidencia , Modelos Logísticos , Prevalencia , Factores de Riesgo , Salud Rural/estadística & datos numéricos , Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis Urinaria/transmisión , Esquistosomiasis mansoni/epidemiología , Esquistosomiasis mansoni/transmisión , Distribución por Sexo , Cuartos de Baño/estadística & datos numéricos , Salud Urbana/estadística & datos numéricos , Yemen/epidemiología
19.
Scand J Immunol ; 51(6): 595-601, 2000 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-10849370

RESUMEN

Cellular immune responses to recombinant (r) Sm14 were examined in chronic, treated patients and uninfected individuals living in an endemic area for schistosomiasis. The lymphocyte proliferative responses and cytokine profile to this antigen were evaluated. Peripheral blood mononuclear cells (PBMC) of all groups studied proliferated to rSm14. However, the highest proliferation index to rSm14 was detected in uninfected endemic normal (EN) individuals who are naturally resistant to schistosomiasis. Regarding the cytokines produced, the levels of interleukin (IL)-5 and IL-10, known as Th2 cytokines, were not statistically different among all groups studied. In contrast, interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha were produced in significantly higher amounts by PBMC of EN individuals following rSm14 stimulation. Additionally, we have determined by flow cytometry that CD4+ T cells from these individuals are the main lymphocyte subpopulation producing IFN-gamma and TNF-alpha. Moreover, we have used rIL-10 or rIFN-gamma, or monoclonal antibodies (MoAb) against these two cytokines to determine their role on cellular reactivity to rSm14. Exogenous IL-10 suppressed T-cell proliferation and neutralization of endogenous IL-10 restored lymphocyte activation and enhanced IFN-gamma and TNF-alpha production in chronically infected patients. In contrast, the addition of anti-IFN-gamma totally abrogated the PBMC proliferation within the EN group. This study demonstrated that IL-10 is an important cytokine down-regulating T-cell responses in chronic schistosomiasis, whereas lymphocyte proliferation in the uninfected resistant group is dependent on IFN-gamma. Taken together these results suggest that Th1 type of immune response induced in EN individuals to a specific schistosome antigen might be associated with resistance to infection and also highlighted the importance of Sm14 as a potential vaccine candidate.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Proteínas Portadoras/farmacología , Proteínas del Helminto/inmunología , Interferón gamma/biosíntesis , Proteínas de Transporte de Membrana , Proteína P2 de Mielina/farmacología , Proteínas de Neoplasias , Proteínas Recombinantes/farmacología , Schistosoma mansoni/inmunología , Esquistosomiasis mansoni/inmunología , Factor de Necrosis Tumoral alfa/biosíntesis , Proteínas Supresoras de Tumor , Adyuvantes Inmunológicos/fisiología , Adolescente , Adulto , Anciano , Animales , División Celular , Citocinas/biosíntesis , Proteínas de Transporte de Ácidos Grasos , Proteína de Unión a los Ácidos Grasos 7 , Proteínas de Unión a Ácidos Grasos , Ácidos Grasos/metabolismo , Femenino , Humanos , Inmunidad Innata , Interleucina-10/inmunología , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/metabolismo , Activación de Linfocitos , Subgrupos Linfocitarios/metabolismo , Masculino , Persona de Mediana Edad , Esquistosomiasis mansoni/epidemiología
20.
Med Trop (Mars) ; 60(4): 351-5, 2000.
Artículo en Francés | MEDLINE | ID: mdl-11436587

RESUMEN

The dynamics of reinfection by Schistosoma haematobium and Schistosoma mansoni after repeated treatment with praziquantel (40 mg/kg body weight, single dose) was studied in a cohort of schoolchildren living in an endemic area. A total of 214 urine and 220 stool samples were collected and examined at three different times, i.e., February 1989, July 1989 and February 1990. Mass chemotherapy was administered at the beginning of study (February 89). Treatment was repeated in children with positive tests at each subsequent sampling. Prevalence rates were 55.1 p. 100, 3.7 p. 100, and 35.0 p. 100 for Schistosoma haematobium and 62.7 p. 100, 46.3 p. 100 and 73.1 p. 100 for Schistosoma mansoni in February 1989, July 1989 and February 1990 respectively (p < 0.001). From July 1989 to February 1990, reinfection was observed in 84.5 p. 100 of children by Schistosoma haematobium versus 57.8 p. 100 by Schistosoma mansoni. The risk of reinfection by Schistosoma haematobium was higher in children between the ages of 7 and 10 years than in children between the ages of 11 and 15 years (p < 0.001), The incidence of intense Schistosoma haematobium egg excretion rose from 0 p. 100 in July 1989 to 6.0 p. 100 in February 1990. The incidence of intense Schistosoma mansoni excretion in February 1990 was 4.5 p. 100. The reinfection rate at 7 months was over 50 p. 100 for both parasite species despite repeated treatment. This finding demonstrates that additional measures such as proper sanitation and vector control are needed to control human schistosomiasis in irrigated rice paddies.


Asunto(s)
Antihelmínticos/uso terapéutico , Visita a Consultorio Médico , Praziquantel/uso terapéutico , Esquistosomiasis Urinaria/tratamiento farmacológico , Esquistosomiasis Urinaria/epidemiología , Esquistosomiasis mansoni/tratamiento farmacológico , Esquistosomiasis mansoni/epidemiología , Adolescente , Distribución por Edad , Agricultura , Niño , Femenino , Humanos , Incidencia , Masculino , Malí/epidemiología , Oryza , Prevalencia , Recurrencia , Esquistosomiasis Urinaria/diagnóstico , Esquistosomiasis Urinaria/parasitología , Esquistosomiasis mansoni/diagnóstico , Esquistosomiasis mansoni/parasitología , Estaciones del Año , Estudiantes/estadística & datos numéricos , Insuficiencia del Tratamiento , Agua/parasitología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA